Evidence that Clostridium difficile TcdC is a membrane-associated protein

Journal of Bacteriology

Volumn 188, Issue 10, 2006, Pages 3716-3720

  Govind, Revathi ^a   Vediyappan, Govindsamy ^a   Rolfe, Rial D ^a   Fralick, Joe A ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; POLYCLONAL ANTIBODY; PROTEIN;

ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CLOSTRIDIUM DIFFICILE; GENE; GENE EXPRESSION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMEMBRANOUS COLITIS; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATASES; ANTIBODIES; BACTERIAL PROTEINS; BACTERIAL TOXINS; BASE SEQUENCE; CLOSTRIDIUM DIFFICILE; DNA PRIMERS; KINETICS; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

CLOSTRIDIUM DIFFICILE;

EID: 33646586338     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.188.10.3716-3720.2006     Document Type: Article

References (20)

1. Bartlett, J. G. 1985. Treatment of Clostridium difficile colitis. Gastroenterology 89:1192-1195.
2. Bongaerts, G. P., and D. M. Lyerly. 1994. Role of toxins A and B in the pathogenesis of Clostridium difficile disease. Microb. Pathog. 17:1-12.
3. Braun, V., T. Hundsberger, P. Leukel, M. Sauerborn, and C. von Eichel-Streiber. 1996. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181:29-38.
4. Candela, T., and A. Fouet. 2005. Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol. Microbiol. 57:717-726.
5. Dartigalongue, C. D. Missiakas, and S. Raina. 2001. Characterization of the Escherichia coli sigma E regulon. J. Biol. Chem. 276:20866-20875.
6. Deckers-Hebestreit, G., and K. Altendorf. 1986. Accessibility of F0 subunits from Escherichia coli ATP synthase. A study with subunit specific antisera. Eur. J. Biochem. 161:225-231.
7. Hammond, G. A., and J. L. Johnson. 1995. The toxigenic element of Clostridium difficile strain VPI 10463. Microb. Pathog. 19:203-213.
8. E is associated with its progression through three patterns of subcellular localization during sporulation in Bacillus subtilis. J. Bacteriol. 180:2426-2433.
9. Hundsberger, T., V. Braun, M. Weidmann, P. Leukel, M. Sauerborn, and C. von Eichel-Streiber. 1997. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur. J. Biochem. 244:735-742.
10. Kolberg, J., E. A. Hoiby, R. Lopez, and K. Sletten. 1997. Monoclonal antibodies against Streptococcus pneumoniae detect epitopes on eubacterial ribosomal proteins L7/L12 and on streptococcal elongation factor Ts. Microbiology 143:55-61.
11. Krukonis, E. S., R. R. Yu, and V. J. Dirita. 2000. The Vibrio cholerae ToxR/TcpP/ToxT virulence cascade: distinct roles for two membrane-localized transcriptional activators on a single promoter. Mol. Microbiol. 38:67-84.
12. Loo, V. G., L. Poirier, M. A. Miller, M. Oughton, M. D. Libman, S. Michaud, A. M. Bourgault, T. Nguyen, C. Frenette, M. Kelly, A. Vibien, P. Brassard, S. Fenn, K. Dewar, T. J. Hudson, R. Horn, P. Rene, Y. Monczak, and A. Dascal. 2005. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449.
13. Mani, N., and B. Dupuy. 2001. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc. Natl. Acad. Sci. USA 98:5844-5849.
14. Mani, N., D. Lyras, L. Barroso, P. Howarth, T. Wilkins, J. I. Rood, A. L. Sonenshein, and B. Dupuy. 2002. Environmental response and autoregulation of Clostridiiim difficile TxeR, a sigma factor for toxin gene expression. J. Bacteriol. 184:5971-5978.
15. McDonald, L. C., G. E. Killgore, A. Thompson, R. C. Owens, Jr., S. V. Kazakova, S. P. Sambol, S. Johnson, and D. N. Gerding. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
16. Moncrief, J. S., L. Zheng, L. M. Neville, and D. M. Lyerly. 2000. Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR. J. Clin. Microbiol. 38:3072-3075.
17. Soehn, F., A. Wagenknecht-Wiesner, P. Leukel, M. Kohl, M. Weidmann, C. von Eichel-Streiber, and V. Braun. 1998. Genetic rearrangements in the pathogenicity locus of Clostridium difficile strain 8864-implications for transcription, expression and enzymatic activity of toxins A and B. Mol. Gen. Genet. 258:222-232.
18. Spigaglia, P., and P. Mastrantonio. 2002. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J. Clin. Microbiol. 40:3470-3475.
19. Voth, D. E., and J. D. Ballard. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
20. Warny, M., J. Pepin, A. Fang, G. Killgore, A. Thompson, J. Brazier, E. Frost, and L. C. McDonald. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084.